Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
South Egypt Cancer Institute
University of Colorado, Denver
CairnSurgical, Inc.
Wake Forest University Health Sciences
University Hospital, Montpellier
British University In Egypt
The Hong Kong Polytechnic University
Hospital Universitari de Bellvitge
IRCCS San Raffaele
University of the West of England
Columbia University
The University of Texas at Dallas
Georgetown University
Tomsk National Research Medical Center of the Russian Academy of Sciences
Wits Health Consortium (Pty) Ltd
University of Hail
University of Kansas Medical Center
Rigshospitalet, Denmark
National Cancer Institute, Egypt
University of Alberta
Cairo University
Universiti Sains Malaysia
MGH Institute of Health Professions
University of Bath
Institut de Radioprotection et de Surete Nucleaire
University of Alcala
Ataturk University
Jules Bordet Institute
Mabwell (Shanghai) Bioscience Co., Ltd.
UNICANCER
Blue Note Therapeutics
LS BioPath
Damanhour University
West China Hospital
Fred Hutchinson Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University of Kansas Medical Center
University Hospital, Ghent
Johns Hopkins University
Northwestern University
National Cancer Institute, Egypt
Centre Paul Strauss
West Virginia University
National Health Service, United Kingdom
Mount Mary University
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Sanofi
Federal University of Maranhao